30.01.2013 Views

2009 Annual Report - CRH

2009 Annual Report - CRH

2009 Annual Report - CRH

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

which mature after more than one<br />

year. In addition, at year-end the<br />

Group held €1.6 billion of undrawn<br />

committed facilities, which had an<br />

average maturity of 2 years.<br />

At year-end <strong>2009</strong>, 96% of the<br />

Group’s cash, short-term deposits<br />

and liquid resources had a<br />

maturity of six months or less.<br />

Shareholders’ Equity<br />

The increase of €1.55 billion in total<br />

shareholders’ equity (capital and<br />

reserves attributable to <strong>CRH</strong>’s equity<br />

shareholders) during <strong>2009</strong> reflects the<br />

proceeds of €1.24 billion from the<br />

March <strong>2009</strong> Rights Issue. The total<br />

movements in equity for the year<br />

are analysed in the Consolidated<br />

Statement of Changes in Equity<br />

(a new primary financial statement)<br />

on page 64 of this <strong>Report</strong>.<br />

Employee Benefits<br />

The assets and liabilities (excluding<br />

related deferred tax) of the defined<br />

benefit pension schemes operated by<br />

various Group companies, computed<br />

in accordance with IAS 19, have been<br />

included on the face of the balance<br />

sheet under retirement benefit<br />

obligations. At end-<strong>2009</strong>, the net<br />

deficit on these schemes amounted<br />

to €454 million (2008: €414 million);<br />

after deducting the related deferred<br />

tax asset, the net liability amounted to<br />

€351 million (2008: €320 million). The<br />

net liability expressed as a percentage<br />

of market capitalisation decreased<br />

from 3.4% at year-end 2008 to 2.6%<br />

at year-end <strong>2009</strong>, reflecting primarily<br />

the impact of the March <strong>2009</strong> Rights<br />

Issue.<br />

Share Price<br />

The Company’s Ordinary Shares<br />

traded in the range €12.55 to €20.70<br />

during <strong>2009</strong>. The year-end share price<br />

was €19.01 (2008: €16.10 restated).<br />

Shareholders recorded a gross return<br />

of 22% (dividends and capital<br />

appreciation) during <strong>2009</strong> following<br />

returns of -22% in 2008, -23% in<br />

2007, +29% in 2006, +28% in 2005<br />

and +23% in 2004.<br />

<strong>CRH</strong> is one of six building materials<br />

companies included in the FTSE<br />

Eurotop 300, a market capitalisationweighted<br />

index of Europe’s largest<br />

300 companies. At year-end <strong>2009</strong>,<br />

<strong>CRH</strong>’s market capitalisation of<br />

€13.3 billion (2008: €9.5 billion)<br />

placed it among the top 3 building<br />

materials companies worldwide.<br />

Insurance<br />

Group headquarters advises management<br />

on different aspects of risk and<br />

monitors overall safety and loss<br />

prevention performance; operational<br />

management is responsible for the<br />

day-to-day management of business<br />

risks. Insurance cover is held for all<br />

significant insurable risks and against<br />

major catastrophe. For any such events,<br />

the Group generally bears an initial<br />

cost before external cover begins.<br />

Legal Proceedings<br />

Group companies are parties to<br />

various legal proceedings, including<br />

some in which claims for damages<br />

have been asserted against the<br />

companies. The final outcome of all<br />

the legal proceedings to which Group<br />

companies are party cannot be<br />

accurately forecast. However, having<br />

taken appropriate advice, we believe<br />

that the aggregate outcome of such<br />

proceedings will not have a material<br />

effect on the Group’s financial<br />

condition, results of operations or<br />

liquidity.<br />

Financial Risk Management<br />

The Board of Directors sets the<br />

treasury policies and objectives of the<br />

Group, which include controls over<br />

the procedures used to manage<br />

financial market risks. These are set<br />

out in detail in note 21 to the financial<br />

statements.<br />

Financing Activity<br />

In March <strong>2009</strong>, the Group issued<br />

approximately 152 million new<br />

Ordinary Shares at €8.40 per share<br />

under the terms of a 2 for 7 Rights<br />

Issue. The total proceeds from this<br />

issue, net of expenses, amounted to<br />

€1.24 billion.<br />

In May <strong>2009</strong>, as part of its ongoing<br />

financing strategy, <strong>CRH</strong> completed its<br />

first transaction in the Eurobond<br />

market with the successful issue of<br />

€750 million notes with a coupon of<br />

7.375% and expiring in May 2014.<br />

This issue further enhances the<br />

Group’s debt maturity profile.<br />

These actions, combined with the<br />

Group’s strong focus on cash<br />

generation, excellent working capital<br />

management and restrained capital<br />

expenditure, leave <strong>CRH</strong> wellpositioned<br />

in terms of debt facilities<br />

and maturity profile. <strong>CRH</strong> remains<br />

committed to maintaining an<br />

investment grade credit rating.<br />

Currency Management<br />

The bulk of the Group’s net worth<br />

(capital and reserves attributable to<br />

equity holders) is denominated in the<br />

world’s two largest currencies – the<br />

US Dollar and the euro – which<br />

accounted for 37% and 34%<br />

respectively of the Group’s net worth<br />

at end-<strong>2009</strong>.<br />

<strong>2009</strong> saw a negative €96 million<br />

currency translation effect on foreign<br />

currency net worth which includes a<br />

€120 million favourable translation<br />

impact on net foreign currency debt.<br />

Sarbanes-Oxley Act<br />

As a result of its NYSE Listing, <strong>CRH</strong> is<br />

subject to the provisions of Section 404<br />

of the Sarbanes-Oxley Act of 2002,<br />

which requires management to<br />

perform an annual assessment of the<br />

effectiveness of internal control over<br />

financial reporting and to report its<br />

conclusions in the Company’s <strong>Annual</strong><br />

<strong>Report</strong> on Form 20-F, filed with the<br />

Securities and Exchange Commission.<br />

For the year ended 31st December<br />

2008, management concluded that the<br />

Company’s internal control over<br />

financial reporting was effective. As<br />

required by US law, Ernst & Young<br />

audited the effectiveness of the<br />

Company’s controls over financial<br />

reporting for 2008 and issued an<br />

unqualified opinion thereon.<br />

Management’s assessment and the<br />

auditors’ report on the effectiveness<br />

of internal controls for the year ended<br />

31st December <strong>2009</strong> will be included in<br />

the <strong>2009</strong> <strong>Annual</strong> <strong>Report</strong> on Form 20-F.<br />

<strong>CRH</strong> 39

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!